https://orcid.org/0000-0002-1012-3624
About the Authors
- Aitana Avendaño Pomares
-
Roles Data curation, Formal analysis, Investigation, Writing – review & editing
Affiliation Translational Hematopathology and Anatomic Pathology Department, Valdecilla/IDIVAL, UNICAN, Santander, Spain
- Laura Rodríguez Merino
-
Roles Data curation, Writing – review & editing
Affiliation Translational Hematopathology and Anatomic Pathology Department, Valdecilla/IDIVAL, UNICAN, Santander, Spain
- Sonia González
-
Roles Data curation, Writing – review & editing
Affiliation Hematology Department, Valdecilla/IDIVAL, Santander, Spain
- Jordi Morata
-
Roles Data curation, Formal analysis, Writing – review & editing
Affiliation Centre Nacional d’Anàlisi Genòmica, Barcelona, Spain
- Raúl Tonda
-
Roles Data curation, Formal analysis, Writing – review & editing
Affiliation Centre Nacional d’Anàlisi Genòmica, Barcelona, Spain
- Patricia Arribas
-
Roles Data curation, Writing – review & editing
Affiliation Translational Hematopathology and Anatomic Pathology Department, Valdecilla/IDIVAL, UNICAN, Santander, Spain
- José Revert
-
Roles Data curation, Writing – review & editing
Affiliation Translational Hematopathology and Anatomic Pathology Department, Valdecilla/IDIVAL, UNICAN, Santander, Spain
- Estrella Carrillo
-
Roles Resources, Writing – review & editing
Affiliation Hematology Department, Hospital Virgen del Rocío, Seville, Spain
- Carlos Grande
-
Roles Resources, Writing – review & editing
Affiliation Hematology Department, Hospital Universitario 12 de octubre, Madrid, Spain
- Josep Maria Roncero
-
Roles Resources, Writing – review & editing
Affiliation Hematology Department, ICO Girona, Girona, Spain
- Jaime Pérez de Oteyza
-
Roles Resources, Writing – review & editing
Affiliation Hematology Department, CIOCC, Madrid, Spain
- Concepción Nicolás
-
Roles Resources, Writing – review & editing
Affiliation Hematology Department, Hospital Central de Asturias, Oviedo, Spain
- Norma Gutierrez
-
Roles Resources, Writing – review & editing
Affiliation Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca (USAL), Salamanca, Spain
- Pau Abrisqueta
-
Roles Resources, Writing – review & editing
Affiliation Hematology Department, Hospital Universitario Vall d’Hebron, Barcelona, Spain
- Antonio Gutiérrez
-
Roles Resources, Writing – review & editing
Affiliation Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain
- Ángel Ramírez-Páyer
-
Roles Resources, Writing – review & editing
Affiliation Hematology Department, Hospital Central de Asturias, Oviedo, Spain
- Alejandro Martin Garcia-Sancho
-
Roles Resources, Writing – review & editing
Affiliation Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca (USAL), Salamanca, Spain
- Eva González-Barca
-
Roles Resources, Writing – review & editing
Affiliation Insititut Català d’Oncologia Hospitalet, Universitat de Barcelona, Insititut d’Investigació Bellvitge (IDIBELL), Barcelona, Spain
- Santiago Montes-Moreno
-
Roles Conceptualization, Formal analysis, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing
* E-mail: Santiago.montes@scsalud.es
Affiliation Translational Hematopathology and Anatomic Pathology Department, Valdecilla/IDIVAL, UNICAN, Santander, Spain
- on behalf of GELTAMO group (Grupo Español de Linfomas y Trasplante Autólogo de Medula Osea), Spain
-
¶The complete membership of the GELTAMO group can be found in the Acknowledgments section.
Affiliation Translational Hematopathology and Anatomic Pathology Department, Valdecilla/IDIVAL, UNICAN, Santander, Spain
Competing Interests
The authors have the following competing interests to declare: Jaime Perez de Oteyza Speakers bureau: Roche, Incyte, Servier Research funding: Pharmacyclics Angel Ramirez Payer Honoraria: Janssen, BMS, Novartis, Roche, EUSA Pharma, Abbvie, Astra Zeneca, Sanofi, Takeda, Incyte, GSK Consulting/Advisory: Janssen, BMS, Pfizer, Roche, Abbvie, Gilead, Novartis, Takeda; Astra Zeneca, Beigene Eva Gonzalez Barca Consultancy: Johnson & Johnson , Abbvie, Kiowa, Beigene, SOBI, Astra-Zeneca Speaker: Johnson & Johnson, Abbvie, Takeda, Astra-Zeneca, Lilly Travel: Johnson & Johnson, Abbvie, AstraZeneca Sonia Gonzalez Speaker´s Honoraria: Roche, Janssen, EusaPharma, Beigene, Takeda, Incyte, KITE-Pharma Advisory Board: Incyte, SOBI, Roche, Abbvie,Astrazeneca Travel/acommodation: Kite-Pharma, Roche Alejandro Martin Garcia-Sancho Honoraria and or consulting fees: Abbvie, AstraZeneca, BeiGene, BMS, Genmab, Gilead / Kite, GSK, Ideogen, Incyte, Janssen, Kyowa Kirin, Lilly, Miltenyi, Regeneron, Roche, Sobi, Takeda Research support: Gilead / Kite Santiago Montes-Moreno Speaker´s Honoraria: Roche, Janssen, Recordati Rare Diseases There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The rest of co-authors do not declare any potential conflict of interest related to this paper.